Using immune risk score to guide recovery after stem cell transplant
Part of Immune system & allergy clinical trials.
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older
- You are getting a stem cell transplant from a half-matched donor (haploidentical transplant)
- You are willing and able to sign a consent form to take part in the study
- You have not had more than one stem cell transplant before
- You do not have any mental or medical issues that would make it hard to follow the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your autonomic nervous system (the part that controls heartbeat and digestion) affects the risk of graft-versus-host disease (a condition where donor cells attack your body) after a half-matched stem cell transplant. You may be able to join if you are older than 16 and receiving a half-matched transplant from a family donor.
This trial tests whether a new test can help prevent a serious complication called graft-versus-host disease (where donor cells attack your body) after a half-matched stem cell transplant. If you qualify, you may receive the study drug ruxolitinib to lower your risk.
This study looks at how your immune system “rebuilds” after certain cell-based cancer treatments or stem cell transplants. It may help researchers better understand why immune recovery differs between people and how to improve protection against infections.
This study looks at how your immune system (specifically B cells) rebuilds after a stem cell transplant. It may help doctors understand recovery and improve future treatments for blood cancers.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
This study is for people who have had a stem cell or solid organ transplant. It aims to predict who might get a serious infection and help doctors manage their care better.
Hear when a new Transplant-Related Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.